Clinical Trials Browser

Interventional × Neurocognitive Disorders × Clear all

NCT05522387 2026-02-27

An Open-Label Extension of XPro1595 in Patients With Alzheimer's Disease

Phase 2 Terminated

Alzheimer Disease, Mental Disorders, Brain Diseases, Central Nervous System Diseases, Dementia, Inflammation, Nervous System Diseases, Neurodegenerative Diseases, Neurocognitive Disorders, Tauopathies

NCT06073717 2025-02-21

BRAINonFIT

Phase NA Active not recruiting

Motor Activity, Neurocognitive Disorders, Cognitive Dysfunction

NCT05633095 2023-03-24

The Pilot Study of Medical Device-Neuclare for Patients With Mild Cognitive Disorder and Early Dementia

Phase NA Unknown

Dementia, Lymphoma, Follicular, Neurocognitive Disorders

NCT02810899 2016-09-29

Dexmedetomidine and Intelligence Development in Pediatric Patients Undergoing Craniotomy

Phase 4 Completed

Brain Neoplasms, Neurocognitive Disorders